第 1 到 10 筆結果,共 10 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2017 | Rifamycin SV MMX for the treatment of traveler’s diarrhea | SHU-WEN LIN ; CHUN-JUNG LIN ; JYH-CHIN YANG | Expert Opinion on Pharmacotherapy | 4 | 2 | |
2 | 2015 | High-dose dual therapy is superior to standard first-line or rescue therapy for helicobacter pylori infection | JYH-CHIN YANG ; CHUN-JUNG LIN ; Wang H.-L.; Chen J.-D.; Kao J.Y.; CHIA-TUNG SHUN ; Lu C.-W.; BOR-RU LIN ; MING-JIUM SHIEH ; MING-CHU CHANG ; YU-TING CHANG ; SHU-CHEN WEI ; Lin L.-C.; Yeh W.-C.; Kuo J.-S.; CHIEN-CHIH TUNG ; Leong Y.-L.; Wang T.-H.; Wong J.-M. | Clinical Gastroenterology and Hepatology | 153 | 131 | |
3 | 2014 | Treatment of Helicobacter pylori infection: Current status and future concepts | JYH-CHIN YANG ; Lu C.-W.; CHUN-JUNG LIN | World Journal of Gastroenterology | 130 | 119 | |
4 | 2013 | Improved dissolution rate and oral bioavailability of lovastatin in red yeast rice products | Chen C.-H.; JYH-CHIN YANG ; Uang Y.-S.; CHUN-JUNG LIN | International Journal of Pharmaceutics | 64 | 52 | |
5 | 2012 | Differential inhibitory effects of proton pump inhibitors on the metabolism and antiplatelet activities of clopidogrel and prasugrel | Chen C.-H.; JYH-CHIN YANG ; Uang Y.-S.; CHUN-JUNG LIN | Biopharmaceutics and Drug Disposition | 19 | 15 | |
6 | 2012 | Interaction between red yeast rice and CYP450 enzymes/P-glycoprotein and its implication for the clinical pharmacokinetics of lovastatin | Chen C.-H.; Uang Y.-S.; Wang S.-T.; JYH-CHIN YANG ; CHUN-JUNG LIN | Evidence-based Complementary and Alternative Medicine | 32 | 19 | |
7 | 2011 | Role of omeprazole dosage and cytochrome P450 2C19 genotype in patients receiving omeprazole-amoxicillin dual therapy for Helicobacter pylori eradication | JYH-CHIN YANG ; Wang H.-L.; Chern H.-D.; CHIA-TUNG SHUN ; BOR-RU LIN ; CHUN-JUNG LIN ; Wang T.-H. | Pharmacotherapy | 42 | 33 | |
8 | 2010 | CYP2C19 genotypes in the pharmacokinetics/pharmacodynamics of proton pump inhibitor-based therapy of Helicobacter pylori infection | JYH-CHIN YANG ; CHUN-JUNG LIN | Expert Opinion on Drug Metabolism and Toxicology | 48 | 42 | |
9 | 2009 | Pharmacokinetic- pharmacodynamic analysis of the role of CYP2C19 genotypes in short-term rabeprazole-based triple therapy against Helicobacter pylori | JYH-CHIN YANG ; Yang Y.-F.; Uang Y.-S.; CHUN-JUNG LIN ; Wang T.-H. | British Journal of Clinical Pharmacology | 14 | 14 | |
10 | 2003 | Time-dependent amplified pharmacokinetic and pharmacodynamic responses of rabeprazole in cytochrome P450 2C19 poor metabolizers | CHUN-JUNG LIN ; JYH-CHIN YANG ; Uang Y.-S.; Chern H.-D.; Wang T.-H. | Pharmacotherapy | 21 | 16 |